| Protocol Title | Name of DFG Statistician | Name of PI | DFG | Year of Submission |
| A Pilot Study assessing the sterilization of urine from urinary diversion after chlorhexidine irrigation in patients undergoing radical cystectomy | Himanshu Joshi | John Sfakianos | GU | 2023 |
| Efficacy of Topical 0.5% Timolol Maleate Solution For Decreased Wound Healing Time in Acute Surgical Wounds Left to Heal by Secondary Intent | Asem Berkalieva | Jesse Lewin | Neuro/Sarcoma/Melanoma | 2023 |
| A Phase 2 Study of Narazaciclib (ON 123300) in Combination with endocrine therapy for patients with HR+ Her2- breast cancer who progressed on CDK4/6 inhibitor therapy | Marcio Diniz | Dr. Joseph Sparano | Breast | 2023 |
| Improving Psychological Adjustment and Care Quality for Men on Active Surveillance (ImPACt) | Himanshu Joshi/Asem Berkalieva | Dr. Nihal Mohammed | GU | 2023 |
| Combination Therapy for Sexual Rehabilitation after Pelvic Radiation: A Prospective Feasibility Trial of Pelvic Floor Physical Therapy and Silicone Vaginal Dilator | Asem Berkalieva | Dr. Karyn A. Goodman | GYN | 2023 |
| A phase I trial of Nicotinamide combined with Gemcitabine/Nab-Paclitaxel chemotherapy in patients with metastatic pancreatic adenocarcinoma | Marcio Diniz/Asem Berkalieva | Dr. Ana Acuna-Villaorduna | GI | 2023 |
| Single Institution, Phase II Study of ctDNA-guided Immunotherapy-based Therapy in Treatment-naïve Advanced Non-Small Cell Lung Cancer (CITAN) | Grace Van Hyfte | Dr. Philip C. Mack | Lung | 2023 |
| A Phase I/II Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the combination of oral ON 123300 and dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma | Erin Moshier/Asem Berkalieva | Dr. Adriana Rossi | Heme | 2023 |
| Pacritinib in combination with azacitidine in patients with chronic myelomonocytic leukemia | Erin Mosher | Dr. Douglas Tremblay | Heme | 2023 |
| A Phase 1 Trial of Intrapleural AllocetraTM given as monotherapy and in conjunction with Ipilimumab/Nivolumab for the treatment of relapsed/refractory advanced MPM and NSCLC | Grace Van Hyfte | Dr. Thomas Marron | Lung | 2023 |
| Tisch Cancer Institute—A Phase 1/2 study of combined treatment with dupilumab (anti-IL-4Ra) and cemiplimab (anti-PD-1) in patients with early-stage, resectable NSCLC | Grace Van Hyfte | Dr. Thomas Marron | Lung | 2023 |
| Pilot Study assessing the feasibility of recruitment and adherence of subjects to a Lifestyle (PRO-LIFE) program of carefully protocoled diet, physical exercise and mindfulness activities aimed at improving global quality of life (which includes mental health and anxiety tolerance measurements) and long term disease outcomes for patients with localized prostate cancer. | Himanshu Joshi / Asem Berkalieva | Dr. Zachary Dovey | GU | 2022 |
| Low-Dose MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial | Erin Moshier / Asem Berkalieva | Dr. John Mascarenhas | Heme | 2022 |
| A single-center, single-arm, open-label phase IIA clinical trial to investigate efficacy and safety of ritlecitinib (PF-06651600) in patients with cutaneous T cell lymphomas | Nicole Zubizarreta | Dr. Patrick Brunner | Neuro/Sarcoma/Melanoma | 2022 |
| Hair Regrowth with Dutasteride during Breast Cancer Treatment | Erin Moshier / Asem Berkalieva | Dr. Angela Lamb | Breast | 2022 |
| A phase IV study of the ApricityRxTM application to improve treatment outcomes of ethnic/racial minority non-small cell lung cancer (NSCLC) patients receiving immunotherapy | Grace Van Hyfte | Dr. Rajwanth Veluswamy | Lung | 2022 |
| A Single-Center, Open-Label, Single-Arm, Phase I Study with Dose Expansion Cohort of Sacituzumab Govitecan in Combination with Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer | Erin Moshier / Asem Berkalieva | Dr. Amy Tiersten | Breast | 2022 |
| Robotic-Assisted Laparoscopic Prostatectomy and SAFE (Saline-assisted fascial engorgement) nerve preservation guided by Micro-ultrasound: A Single-center Prospective Randomized Controlled Trial | Himanshu Joshi | Dr. Ashutosh Tewari | GU | 2022 |
| TIER – PALLIATIVE CARE: A POPULATION-BASED CARE DELIVERY MODEL TO MATCH EVOLVING PATIENT NEEDS TO PALLIATIVE CARE SERVICES FOR COMMUNITY-BASED PATIENTS WITH HEART FAILURE OR CANCER (TIER-PC) | Vivien Huang | Dr. Laura Gelfman | Lung | 2022 |
| A Phase II Study of the Effects of Pembrolizumab on Quality of Life for Patients with Treatment-Naïve, Advanced or Metastatic NSCLC and Poor Performance Status | Vivien Huang | Dr. Deborah Doroshow | Lung | 2022 |
| Tisch Cancer Institute—A Phase 1/2 study of combined treatment with dupilumab (anti-IL- 4R ) and cemiplimab (anti-PD-1) in patients with early-stage, resectable NSCLC |
Grace Van Hyfte | Dr. Thomas Marron | Lung | 2023 |
| ImeTELstat with venetoclax Or azacitidine in acute MyEloid leukemia in RelapsE (TELOMERE TRIAL) | Erin Moshier | Dr. Douglas Tremblay | Heme | 2022 |
| Phase II randomized controlled trial aimed at assessing the influence of a Lifestyle (PRO-LIFE) program of carefully protocolled diet, physical exercise and mindfulness activities on quality of life, mental health and long term disease outcomes for prostate cancer | Himanshu Joshi | Dr. Zachary Dovey | GU | 2022 |
| A Phase I open label peri-prostatic neuraxial block with lidocaine and ethanol in high-risk localized prostate cancer | Himanshu Joshi | Dr. Ali Zahalka | GU | 2022 |
| A phase I, open label study employing the topical immunomodulator diphencyprone to improve efficacy of PD-1 or PD-L1 immune checkpoint inhibition in the treatment of advanced cancer with cutaneous metastases | Nicole Zubizarreta / Jose Correa da Rosa | Dr. Nicholas Gulati | Neuro/Sarcoma/Melanoma | 2022 |
| The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal SCCA (SIRS 2.0 Trial) | Vivien Huang | Dr. Raymond Chai | H&N | 2021 |
| Surgical Management of Pancreatic Ductal Adenocarcinoma Liver Oligometastases | John Mandeli | Dr. Noah Cohen | GI | 2021 |
| Neoadjuvant PD-1 Immune Checkpoint Blockade with Pembrolizumab Combined with Tumor Treating Fields of Patients with Recurrent Glioblastoma (rGBM): A Multicenter Study | Himanshu Joshi | Dr. Constantinos Hadjipanayis | Neuro/Sarcoma/Melanoma | 2021 |
| A Technical Feasibility Study of Wrapping the Prostatic Neurovascular Bundle with NeuroShieldTM during Nerve-sparing Robot-assisted Laparoscopic Prostatectomy | Nicole Zubizarreta | Dr. Vinayak Wagaskar / Dr. Ash Tewari | GU | 2021 |
| Neoadjuvant PD-1 Immune Checkpoint Blockade with Pembrolizumab Combined with Tumor Treating Fields of Patients with Recurrent Glioblastoma (rGBM): A Multicenter Study | Himanshu Joshi | Dr. Constantinos Hadjipanayis | Neuro/Sarcoma/Melanoma | 2021 |
| DISRUPT: Diversity and IncluSion in Research Underpinning Prevention and Therapy trials | Parul Agarwal | Dr. Nina Bickell | Breast | 2021 |
| Serial Response and Biomarker-Guided Steroid Taper for Children with GVHD | Umut Ozbek | Dr. John Levine | Heme | 2021 |
| Serial Response and Biomarker-Guided Steroid Taper to Reduce Treatment Complications in Low Risk Acute Graft-vs-Host Disease (GVHD) | Umut Ozbek | Dr. John Levine | Heme | 2021 |
| Single-center Randomized Single-Blind Placebo-Controlled Pilot Study of Botulinum Neurotoxin for Neuromodulation of Erectile Function After Prostatectomy | Nicole Zubizarreta/Tony Zhong | Dr. Robert Valenzuela | GU | 2021 |
| Prospective, Randomized, Single-blind study of using AirSeal® Insufflation System versus Conventional Pneumatic System during Robotic Prostatectomy | Nicole Zubizarreta/Tony Zhong | Dr. Ashutosh Tewari | GU | 2021 |
| A Phase III randomized study using wearable devices and performance monitors in Bladder Cancer Patients Undergoing Cystectomy | Himanshu Joshi | Dr. Peter Wikilund | GU | 2021 |
| A Multicenter Phase 1-DEC (Dose expansion cohort) Open-label Study of Iberdomide (CC-220) in combination with Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma | Erin Moshier | Dr. Samir Parekh | Heme | 2021 |
| Pilot trial of colchicine to suppress pro-tumorigenic inflammation in patients with urothelial cancer and other solid tumors | Tony Zhong | Dr. Matthew Galsky | Phase I Therapeutics | 2021 |
| A Pilot, Rapid Sequencing of First Line Cabozantinib, Ipilimumab and Nivolumab, and Lenvatinib and Everolimus in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma | Tony Zhong/Nicole Zubizarreta | Dr. Che-Kai Tsao | GU | 2021 |
| A Phase 2 Study of Bintrafusp Alfa for First Line Treatment of Stage IV Lung Adenocarcinoma Patients with STK11/LKB1 Mutations | John Mandeli | Dr. Rajwanth Veluswamy | Lung | 2021 |
| Phase I Study of Cemiplimab‐ TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Vivien Huang | Dr. Krzysztof Misiukiewicz | H&N | 2021 |
| A Phase 1b/2 trial of Dupilumab given in conjunction with PD-(L)1 blockade in the treatment of relapsed/refractory metastatic NSCLC | John Mandeli | Dr. Thomas Marron | Lung | 2021 |
| Single-center, Phase II, double-blinded, Randomized Double-Blind Placebo-Controlled Study of Botulinum Neurotoxin for Restoration of Erectile Function After Prostatectomy | Tony Zhong / Nicole Zubizarreta | Dr. Robert Valenzuela | GU | 2021 |
| A Phase IA/IB Trial of Leflunomide in Patients with PTEN-null Advanced Solid Malignancies | Vivien Huang | Dr. Deborah Doroshow | Phase I Therapeutics | 2021 |
| A Non-Randomized Phase II Study of the Reduction in Rectal V100 with the Use of Rectal Spacer Hydrogel in the Management of Intermediate Risk Prostate Cancer Treated with Combined Modality Radiation Therapy | Erin Moshier | Dr. Richard Stock | GU | 2020 |
| Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | Joel Erblich | Dr. Guy Montgomergy | Breast | 2020 |
| A Pilot Study of Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy Combined with Chemotherapy in Pancreatic Adenocarcinoma | Erin Moshier / John Mandeli | Dr. Deidre Cohen | GI | 2020 |
| Phase II Trial of In-Situ Autologous Vaccination with Intratumoral and Systemic Hiltonol® (Poly-ICLC) administered to Patients on Active Surveillance | John Mandeli | Dr. Ashutosh Tewari | GU | 2020 |
| Early Feeding after free flap reconstruction of oral cavity defects: A feasibility Trial | Vivien Huang | Dr. Mohemmed N. Khan | H&N | 2020 |
| Reprogramming the Adult and Pediatric High-Grade Glioma Tumor Microenvironment: Dendritic Cell Vaccine Loaded with Personalized Neoantigen Synthetic Long Peptides in Combination with Immune Checkpoint Blockade | John Mandeli | Dr. Adilia Hormigo | Neuro/Sarcoma/Melanoma | 2020 |
| Effect of Talc Slurry within 24 hours of Indwelling Pleural Catheter Placement on Pleurodesis Rates in Patients with Malignant Pleural Effusion: A Randomized Clinical Trial | Vivien Huang | Dr. Udit Chaddha | Lung | 2020 |
| A Phase I/II Trial of Venetoclax in Combination with Nab-paclitaxel and Atezolizimub in Women with Metastatic Triple Negative Breast Cancer | John Mandeli | Dr. Charles Shapiro | Breast | 2020 |
| Collaborative Phase I Study of Cemiplimab‐ TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Vivien Huang | Dr. Krzysztof Misiukiewicz | H&N | 2020 |
| A Phase 0 Trial of the Immune-Impact by HB-201 in Treatment Naïve Subjects Undergoing Curative Therapy with Local Human Papillomavirus 16 Positive (HPV 16+) Cancers | Vivien Huang | Dr. Marshall Posner | H&N | 2020 |
| Change of Proliferation Index with Fulvestrant in Hormone Receptor Positive Breast Cancer with Cyclin D1 Overexpression Status: A Pilot Trial | Meng Ru | Dr. Amy Tiersten | Breast | 2020 |
| RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC | Vivien Huang | Dr. Marshall Posner | H&N | 2020 |
| A Phase 1/2 Trial of Cemiplimab and Dupilumab in the Treatment of Metastatic Solid Tumors, and as Neoadjuvant Treatment of Resectable Pancreatic Adenocarcinoma | John Mandeli | Dr. Thomas Marron | Phase I Therapeutics | 2020 |
| Adipose Derived Stem Cells in Stromal Vascular Fraction by Intracavernosal Injection for the treatment of Erectile dysfunction post Robot-assisted Laparoscopic Prostatectomy | Tony Zhong | Dr. Ashutosh Tewari | GU | 2020 |
| Phase I Study of Dual Immune Checkpoint Blockade (Anti-PD-L1 (Durvalumab) (MEDI4736) and Anti-CTLA4 (Tremelimumab) Plus Yttrium-90 (Y-90) Radioembolization & Stereotactic Body Radiation Therapy (SBRT) in Refractory Metastatic MSS (Microsatellite Stable) Colorectal Cancer with Liver Metastases | Erin Moshier | Dr. Karyn A. Goodman | GI | 2020 |
| EFFECTIVENESS OF CIRCULATING TUMOR DNA ANALYSIS AT THE TIME OF BRONCHOSCOPIC EVALUATION FOR ADVANCED LUNG MALIGNANCIES | Vivien Huang | Dr. Stacey-Ann Brown | Lung | 2020 |
| A phase I open label peptide based vaccine in patients with myeloproliferative neoplasm harboring CALR mutations | Erin Moshier | Dr. Michal Bar-Natan | Heme | 2019 |
| A Multicenter Study to Assess the Feasibility of Aminolevulinic Acid (ALA) in Pediatric Brain Tumor Patients | Joyce Lin | Dr. John Ruge / Dr. Constantinos Hadjipanayis (Mount Sinai) | Pediatrics | 2019 |
| A Phase I Trial of Radiation, Temozolomide, and Concomitant and Adjuvant Onc201 after Surgical Resection for Newly Diagnosed Glioblastoma | Meng Ru | Dr. Sonam Sharma | Neuro/Sarcoma/Melanoma | 2019 |
| Phase I, open-label, single-center proof of concept study designed to test the safety and tolerability of PGV001-based personalized multi-peptide vaccines in combination with CDX-301 in subjects with a history of prostate cancer, in the adjuvant setting. | John Mandeli | Dr. Ashutosh Tewari | GU | 2019 |
| Somatic to Autonomic Nerve Grafting for the Treatment of Erectile Dysfunction post Radical Prostatectomy | Tony Zhong | Dr. Ashutosh Tewari | GU | 2019 |
| A Phase II, Multicenter Study to Determine the Safety Profile of Aminolevulinic Acid (ALA) in Pediatric Brain Tumor Patients | Joyce Lin (Present) / Yi Li (Advocate Children’s Hospital) / Xiangnan Zhang (Mt Sinai Dept Neurosurgery) | Dr. John Ruge (Midwest Children’s Brain Tumor Center) / Dr. Robert Kellogg (Advocate Children’s Hospital) / Dr. Constantinos Hadjipanayis (Mt Sinai Study Sponsor) | Pediatrics | 2019 |
| Randomized experimental design to evaluate the utility of EMDR-RTEP Therapy for Head and Neck Cancer patients with Post Traumatic Stress | Vivien Huang | Dr. Marshall Posner | H&N | 2019 |
| A Multicenter, Phase IB/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer | Meng Ru | Dr. Chrystal Landry | Breast | 2019 |
| A Single-center Phase I/II Study to Evaluate the Safety and Efficacy of Zeaxanthin in Patients with Stage III Unresectable and Stage IV Metastatic Non-ocular and Ocular Melanoma | Tony Zhong | Dr. Philip Friedlander | Neuro/Sarcoma/Melanoma | 2019 |
| Assessing the feasibility of a mind-body intervention for early stage lung cancer surgical patients | Naomi Alpert | Dr. Rebecca M. Schwartz | Lung | 2019 |
| A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment | John Mandeli | Dr. Rajwanth Veluswamy | Lung | 2019 |
| Feasibility study on the recruitment of a prospective cohort trial on robotic vs transanal total mesorectal excision | Nicole Zubizarreta | Dr. Patricia Sylla | GI | 2019 |
| Predicting response to immunotherapy in hepatocellular carcinoma by dissecting the gut microbiome: a pilot study | Vivien Huang | Dr. Celina Ang | Liver | 2019 |
| Determining the role of a prophylactic coronoidectomy to prevent post-radiation trismus | Vivien Huang | Dr. Mark L. Urken | H&N | 2019 |
| EchoMark: Feasibility study for resorbable implanted flap checking device | Joyce Lin | Dr. Brett Miles | H&N | 2019 |
| An open label phase II study to evaluate the safety and efficacy of Ipatasertib (GDC-0068) in combination with paclitaxel in platinum-resistant recurrent epithelial ovarian cancer | Meng Ru | Dr. Amy Tiersten | GYN | 2019 |
| Tisch Cancer Institute—BMS Study # CA027-005: Neoadjuvant Nivolumab + BMS-813160 (CCR2/5-inhibitor) or BMS-986253 (anti-IL-8) for NSCLC or HCC | John Mandeli | Dr. Thomas Marron | Lung | 2019 |
| Split-Thickness Skin Graft Donor Site Dressing Phase II Randomized Controlled Trial in Head and Neck Cancer Reconstruction | Vivien Huang | Dr. Brett Miles | H&N | 2019 |
| A palliative hypnosis intervention for pain in individuals with solid tumor metastasis: A preliminary study | Gary Winkel | Dr. Guy Montgomergy | Breast | 2019 |
| Use of perioperative pain blocks in urological surgery: A Phase III Randomized single blind single center three arm non-inferiority trial | Erin Moshier | Dr. Daniel Rosen | GU | 2018 |
| The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial | Vivien Huang | Dr. Alfred-Marc Iloreta | H&N | 2018 |
| Definitive and Adjuvant Hypofractionated Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) | Umut Ozbek | Dr. Richard Bakst | H&N | 2018 |
| A Matched Case Clinical Registry – Efficacy of AmnioFix® in the Prevention of Post-Operative Salivary Leaks Following Head and Neck Surgery | Vivien Huang | Dr. Brett Miles | H&N | 2018 |
| PHASE II MULTICENTER STUDY OF NATALIZUMAB PLUS STANDARD STEROID TREATMENT FOR HIGH RISK ACUTE GRAFT-VERSUS-HOST DISEASE | Umut Ozbek | Dr. John Levine | BMT | 2018 |
| A Prospective, Single-Blind, Randomized Controlled Trial to Evaluate Cold Saline Irrigation to Reduce Pain after Transoral Robotic Surgery | Vivien Huang | Dr. Eric Genden | H&N | 2018 |
| A Phase 2 Study of Daratumumab in Combination with Dose-Attenuated Bortezomib, Lenalidomide, and Dexamethasone in Elderly Newly Diagnosed Multiple Myeloma Patients | Erin Moshier | Dr. Ajai Chari | Heme | 2018 |
| Change of Proliferation Index with Fulvestrant in Hormone Receptor + Breast Cancer | Meng Ru | Dr. Amy Tiersten | Breast | 2018 |
| Impact of a Child Life Specialist and Animal Assisted Therapy Intervention Utilizing a Facility Dog on Perception of Pediatric Patient Distress During Intravenous Catheter Placement, Venipuncture, and Port Access | A. Weinberg | Dr. William Beau Mitchell | Pediatrics | 2018 |
| A Phase 1b/2 Single-Arm, Multi-Cohort Trial of Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC and HNSCC | John Mandeli | Dr. Thomas Marron | Phase I Therapeutics | 2018 |
| Role of Continuous Local Infusion of Ropivacaine for Post-Operative Pain Management in Patients Receiving Osseocutaneous Free Flaps | Vivien Huang | Dr. Brett Miles | H&N | 2018 |
| Phase 0/1 study of valproic acid expanded cord blood stem cells as allogeneic grafts for adults with hematological malignancies | Umut Ozbek | Dr. Alla Keyzner | BMT | 2018 |
| Phase II Randomized Clinical Trial Examining the Effects of Hypnotic Cognitive Therapy vs Mindfulness Meditation for Fear of Recurrence in Head & Neck Cancer Survivors | Vivien Huang | Dr. Ilya Likhterov | H&N | 2018 |
| Phase II Randomized Clinical Trial Examining the Effects of Hypnotic Cognitive Therapy vs Mindfulness Meditation for Fear of Recurrence in Head & Neck Cancer Survivors | Vivien Huang | Dr. Ilya Likhterov | H&N | 2018 |
| ITACITINIB MONOTHERAPY FOR LOW RISK GRAFT-VS-HOST DISEASE | Umut Ozbek | Dr. John Levine | BMT | 2018 |
| In Situ Vaccination with Flt3L, Radiation, and Poly-ICLC Combined with Pembrolizumab in Patients with Non-Hodgkin’s Lymphoma, Metastatic Breast Cancer, and Head and Neck Squamous Cell Carcinoma | Erin Moshier | Dr. Joshua Brody | Phase I Therapeutics | 2018 |
| Improving PPV3 using Contrast Enhanced Mammography (CEM) in diagnostic assessment by reducing benign tissue diagnosis (FP3)- A single-arm prospective study | John Mandeli | Dr. Liao | Breast | 2018 |
| A pilot study of Coronary CT Angiography (CCTA) as a predictive tool for short-term cardiac events in patients receiving 5-Fluorouracil (5-FU). | Erin Moshier | Dr. Celina Ang | GI | 2017 |
| Evaluating the immunogenicity of gut microbiota in the tumor microenvironment of patients with early stage colon cancer | John Mandeli | Dr. Miriam Merad | GI | 2018 |
| Accelerated breast RT fractionation in patients receiving systemic therapy | John Mandeli | Dr. Manjeet Chadha | Breast | 2017 |
| A PROOF OF CONCEPT PILOT TRIAL OF ALPHA-1-ANTITRYPSIN FOR PRE-EMPTION OF STEROID-REFRACTORY ACUTE GVHD | Umut Ozbek | Dr. John Levine | BMT | 2017 |
| Priority Assessment for Women with Ovarian Cancer: A Pilot Study | John Mandeli | Dr. Stephanie Blank | GYN | 2017 |
| Prospective Case-Control Study of DILI in High Risk Groups’ | Huiman Barnhart (External Stat) | Dr. Josheph Odin | GU | 2017 |
| Analysis of Blood Specimens for circulating tumor and immune cells | Rachel Jia | Dr. Matthew Galsky | GU | 2017 |
| Choroidal Thickness Measurements in Melanoma Patients treated with Immunotherapy | Umut Ozbek | Dr. Deobhakta | Neuro/Sarcoma/Melanoma | 2017 |
| METABOLIC CHANGES IN MYELOFIBROSIS WITH RUXOLITINIB TREATMENT | Erin Moshier | Dr. John Mascarenhas | Heme | 2017 |
| A Phase I/II Trial of Leflunomide in Women with Previously Treated Metastatic Triple Negative Cancers | John Mandeli | Dr. Charles Shapiro | Breast | 2017 |
| A Phase I/II study on feasibility and efficacy of Upright MP-MRI for screening prostate cancer | Rachel Jia | Dr. Ashutosh Tewari | GU | 2017 |
| Characterization of Prostate Cancer Aggressiveness with Advanced Multiparametric Magnetic Resonance Imaging | Rachel Jia | Dr. Bachir Taouli | GU | 2017 |
| Phase II study of Galunisertib in patients with myelofibrosis | Erin Moshier | Dr. John Mascarenhas | Heme | 2017 |
| A Phase I/II Study of the Addition of Ixazomib to ONC201 and dexamethasone in relapsed and/or refractory multiple myeloma | Erin Moshier | Dr. Ajai Chari | Heme | 2017 |
| Disease Beliefs and Cognition: Effect on Diabetes Management in Older Breast Cancer Survivors | Joel Erblich | Dr. Jenny Lin | Breast | 2017 |
| Assessment of Quality of Life, Prognostic Understanding, and Perceived Goals of Care in Hospitalized Patients with Leukemia or Multiple Myeloma | Gary Winkel | Dr. Cardinale Smith | Heme | 2017 |
| Prostate Cancer Survivors’ and Caregivers’ Health Beliefs and Hypertension Management | Juan Wisnivesky | Dr. Jenny Lin | GU | 2017 |
| Investigator initiated prospective pilot study, single center, for cetuximab in advanced cutaneous squamous cell carcinoma | Erin Moshier | Dr. Desiree Ratner | Neuro/Sarcoma/Melanoma | 2017 |
| A Phase II study on efficacy of Upright MRI for screening prostate cancer | Rachel Jia | Dr. Ashutosh Tewari | GU | 2017 |
| A multi-center phase Ib/II trial of Nivolumab/Ipilimumab-Primed Immunotransplant for relapsed/refractory diffuse large B cell lymphoma for transplant ineligible patients | Erin Moshier | Dr. Joshua Brody | Heme | 2017 |
| A pilot study of the combination of 5-azacitadine (5-AZA) and all-trans retinoic acid (ATRA) for prostate cancer (PCa) with PSA-only recurrence | Rachel Jia | Dr. William Oh | GU | 2017 |
| Direct injection of Poly-ICLC (Hiltonol®) vaccine In Malignant Pleural Mesothelioma | John Mandeli | Dr. Raja Flores | Lung | 2017 |
| A phase II trial of neoadjuvant laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with chemoradiation (carboplatin and taxol) as first line treatment for patients with local regional advanced Gastric cancer | Erin Moshier | Dr. Spiros Hiotis | GI | 2017 |
| Acquisition of human bladder associated specimen to study the causes, diagnosis, and treatment of bladder cancers | Rachel Jia | Dr. John Martignetti | GU | 2017 |
| A Phase I Study Evaluating the Safety of Durvalumab (Anti-PDL1) in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer | Meng Ru | Dr. Amy Tiersten | Breast | 2017 |
| The Clinical Utility of the Frontal Systems Behavior Scale (FrSBe) to Quantify Executive Dysfunction Following Treatment for Localized Breast Cancer | Meng Ru | Dr. Amy Tiersten | Breast | 2017 |
| Racial, Cultural, and Dyadic Relationships Factors Influencing Treatment Decisions about Active Surveillance (AS) for Localized Prostate Cancer (PrCa) | Emma Benn | Dr. Nihal Mohammed | GU | 2017 |
| Phase I Study of PD-L1 Inhibition with Avelumab and in Patients with Recurrent Glioblastoma | John Mandeli | Dr. Adilia Hormigo | Neuro/Sarcoma/Melanoma | 2016 |
| Systematic Light Exposure to treat Fatigue in Breast Cancer Patients | Gary Winkel | Dr. Bill Redd | Breast | 2016 |
| Personalized Cancer Therapy for Patients with Metastatic Medullary Thyroid Cancer (MTC), Colorectal Carcinoma (CRC), and an Exploratory Cohort (EC) | Rachel Jia | Dr. Krzysztof Misiukiewicz | H&N | 2016 |
| A Pilot Feasibility Study Using Wearable Devices in Multiple Myeloma Patients Receiving Outpatient Chemotherapy’ | Madhu Mazumdar | Dr. Samir Parekh | Heme | 2016 |
| The personal patient profile decision support for patients with bladder cancer | Emma Benn | Dr. Nihal Mohammed | GU | 2016 |
| Understanding Unmet Needs of Multiple Myeloma Patients | Kezhen Fei | Dr. Sundar Jagannath/Dr. Nina Bickell | Heme | 2016 |
| Nitazoxanide Combined with FOLFIRI for treatment of Metastatic Colorectal Cancer: Phase I/II Pilot Study | Erin Moshier | Dr. Randy Holcombe | GI | 2016 |
| A Phase 1/2a Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients with Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) | Erin Moshier | Dr. Joshua Brody | Heme | 2016 |
| FEASIBILITY OF EX VIVO CELL BASED IMMUNE THERAPY PRODUCTION DEVELOPED BY GENEIUS BIOTECHNOLOGY FOR PATIENTS WITH EPSTEIN BARR VIRUS POSITIVE HODGKIN`S, NON HODGKIN`S LYMPHOMA AND NASOPHARYNGAL CANCER | Ashley Olson | Dr. Krzysztof Misiukiewicz | H&N | 2016 |
| Phase II Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients with Newly Diagnosed Glioblastoma | John Mandeli | Dr. Adilia Hormigo | Neuro/Sarcoma/Melanoma | 2016 |
| Phase II Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients with Newly Diagnosed Glioblastoma | John Mandeli | Dr. Adilia Hormigo | Neuro/Sarcoma/Melanoma | 2016 |
| A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma | None | Dr. John Sfakianos | GU | 2016 |
| A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, Her2-positive Metastatic Breast Cancer | Ashley Olson | Dr. Amy Tiersten | Breast | 2016 |
| Sarah Miller K07 grant application | Gary Winkel | Dr. Sarah Miller | CPC | 2016 |
| Phase 1/2 study of ixazomib in combination with Cyclophosphamide and Dexamethasone in patients with newly diagnosed Immunoglobulin Light Chain AL Amyloidosis | Umut Ozbek | Dr. Keren Osman | BMT | 2016 |
| Pilot Case-Control Evaluation of a Hybrid Pre-Test Oncology Genetic Counseling Model: “Video + Counseling” Model Versus “Counseling Only” Model for Multi-gene Panel Testing | John Mandeli | Dr. Misha Rashkin | Breast | 2016 |
| A Phase 1/2 Study of In Situ Vaccination with Tremelimumab and IV Durvalumab (MEDI4736) Plus the Toll-like Receptor Agonist PolyICLC in Subjects with Advanced, Measurable, Biopsy-accessible Cancers | John Mandeli | Dr. Nina Bhardwaj | Phase I Therapeutics | 2016 |
| PD-1 inhibition in advanced myeloproliferative neoplasms | Erin Moshier | Dr. John Mascarenhas | Heme | 2016 |
| Circulating tumor cells and Natural Killer cell activity in the prognosis of patients diagnosed with triple negative breast cancer. | John Mandeli | Dr. Hanna Irie | Breast | 2016 |
| Randomized controlled trial of cognitive rehabilitation and psychotherapeutic interventions for neuropsychological dysfunction following treatment for localized breast cancer in women | Ashley Olson | Dr. Amy Tiersten | Breast | 2016 |
| Pilot Study of Atezolizumab plus PGV001, a Multi-Peptide Personalized Neoantigen Vaccine, in Patients with Locally Advanced or Metastatic Urothelial Cancer | Erin Moshier | Dr. Matthew Galsky | GU | 2016 |
| A Phase II study assessing the effect of pembrolizumab induced changes to the NK cell exhaustion phenotype on the efficacy of PD-1 targeted treatment in patients with unresectable stage III or stage IV melanoma | John Mandeli | Dr. Nina Bhardwaj | Neuro/Sarcoma/Melanoma | 2016 |
| The impact of optimism and coping on the experience of side effects of adjuvant chemotherapy in women with early-stage breast cancer | John Mandeli | Dr. Charles Shapiro | Breast | 2016 |
| A Phase II Double Arm Single-Blinded Randomized Screening Clinical Trial to Evaluate the use of AmnioFix® to Facilitate Recovery of Renal Function following Partial Nephrectomy | Ashley Olson | Dr. Ketan Badani | GU | 2016 |
| A Phase II Double Arm Single-Blinded Randomized Screening Clinical Trial to Evaluate the use of AmnioFix® to Facilitate Recovery of Renal Function following Partial Nephrectomy | Ashley Olson | Dr. Ketan Badani | GU | 2016 |
| Comparison in the Change of Proliferation Index between Fulvestrant and Tamoxifen in Cyclin D1 +, Estrogen Receptor + Breast Cancer | John Mandeli | Dr. Amy Tiersten | Breast | 2016 |
| A Phase I Single-Arm Open Label Dose-Escalation Study to Evaluate the Maximum Tolerated Dose, Safety and Cancer Control of CivaSheet® with Radical Prostatectomy and Adjuvant External Beam Radiation Therapy in Patients with High Risk Prostate Cancer | Ashley Olson | Dr. Ketan Badani | GU | 2015 |
| A cross sectional study examining quality of life and the prevalence of use of complementary medicine, spirituality and prayer for health in patients with genitourinary cancers | Ashley Olson | Dr. Jullian Capidoce | GU | 2015 |
| Multicenter Phase II Study of Transanal Total Mesorectal Excision (taTME) With Laparoscopic Assistance for Rectal Cancer | Umut Ozbek | Dr. Patricia Sylla | GI | 2015 |
